These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1503397)

  • 1. Carrier detection of deletions of the Hunter gene by in situ hybridization.
    Stone S; Adinolfi M
    Ann Hum Genet; 1992 May; 56(2):93-7. PubMed ID: 1503397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.
    Wilson PJ; Suthers GK; Callen DF; Baker E; Nelson PV; Cooper A; Wraith JE; Sutherland GR; Morris CP; Hopwood JJ
    Hum Genet; 1991 Mar; 86(5):505-8. PubMed ID: 1901826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iduronate sulfatase gene: isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome.
    Palmieri G; Capra V; Romano G; D'Urso M; Johnson S; Schlessinger D; Morris P; Hopwood J; Di Natale P; Gatti R; Ballabio A
    Genomics; 1992 Jan; 12(1):52-7. PubMed ID: 1733863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the Hunter gene and both DXS466 and DXS304 in a patient with mucopolysaccharidosis type II.
    Beck M; Steglich C; Zabel B; Dahl N; Schwinger E; Hopwood JJ; Gal A
    Am J Med Genet; 1992 Sep; 44(1):100-3. PubMed ID: 1355630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier detection of deletions in female relatives of X-linked disorders by non-isotopic in situ hybridisation.
    Adinolfi M; Stone S; Moralli D
    Bioessays; 1992 Jun; 14(6):421-6. PubMed ID: 1503558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene diagnosis and carrier detection in Hunter syndrome by the iduronate-2-sulphatase cDNA probe.
    Gal A; Beck M; Sewell AC; Morris CP; Schwinger E; Hopwood JJ
    J Inherit Metab Dis; 1992; 15(3):342-6. PubMed ID: 1357230
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular analysis of patients with Hunter syndrome: implication of a region prone to structural alterations within the IDS gene.
    Steén-Bondeson ML; Dahl N; Tönnesen T; Kleijer WJ; Seidlitz G; Gustavson KH; Wilson PJ; Morris CP; Hopwood JJ; Pettersson U
    Hum Mol Genet; 1992 Jun; 1(3):195-8. PubMed ID: 1303177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome).
    Wraith JE; Cooper A; Thornley M; Wilson PJ; Nelson PV; Morris CP; Hopwood JJ
    Hum Genet; 1991 Jun; 87(2):205-6. PubMed ID: 1906048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hunter syndrome among Jews in Israel.
    Ben-Simon-Schiff E; Zlotogora J; Abeliovich D; Zeigler M; Bach G
    Biomed Pharmacother; 1994; 48(8-9):381-4. PubMed ID: 7858175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome.
    Bondeson ML; Malmgren H; Dahl N; Carlberg BM; Pettersson U
    Eur J Hum Genet; 1995; 3(4):219-27. PubMed ID: 8528670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe phenotype in MPS II patients associated with a large deletion including contiguous genes.
    Brusius-Facchin AC; De Souza CF; Schwartz IV; Riegel M; Melaragno MI; Correia P; Moraes LM; Llerena J; Giugliani R; Leistner-Segal S
    Am J Med Genet A; 2012 May; 158A(5):1055-9. PubMed ID: 22492741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis and carrier detection in mucopolysaccharidosis type II by mutation analysis. A 47,XXY male heterozygous for a missense point mutation.
    Bunge S; Steglich C; Lorenz P; Beck M; Xu S; Hopwood JJ; Gal A
    Prenat Diagn; 1994 Sep; 14(9):777-80. PubMed ID: 7845883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis in patients with mucopolysaccharidosis type II suggests that DXS466 maps within the Hunter gene.
    Steglich C; Bunge S; Hulsebos T; Beck M; Brandt NJ; Schwinger E; Hopwood JJ; Gal A
    Hum Genet; 1993 Sep; 92(2):179-82. PubMed ID: 8103756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.
    Schröder W; Petruschka L; Wehnert M; Zschiesche M; Seidlitz G; Hopwood JJ; Herrmann FH
    J Med Genet; 1993 Mar; 30(3):210-3. PubMed ID: 8097259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and phenotypic variation in patients with severe Hunter syndrome.
    Timms KM; Bondeson ML; Ansari-Lari MA; Lagerstedt K; Muzny DM; Dugan-Rocha SP; Nelson DL; Pettersson U; Gibbs RA
    Hum Mol Genet; 1997 Mar; 6(3):479-86. PubMed ID: 9147653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hunter disease in the Spanish population: molecular analysis in 31 families.
    Gort L; Chabás A; Coll MJ
    J Inherit Metab Dis; 1998 Aug; 21(6):655-61. PubMed ID: 9762601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Li P; Bellows AB; Thompson JN
    J Med Genet; 1999 Jan; 36(1):21-7. PubMed ID: 9950361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome.
    Archer IM; Harper PS; Wusteman FS
    Clin Chim Acta; 1981 Apr; 112(1):107-12. PubMed ID: 6786801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.